Nuveen »

Ovid Therapeutics shares owned by Nuveen

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Nuveen from 13F filings

Historical chart of Nuveen investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Nuveen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Nuveen

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.4M 893k 2.69
2025-03-31 $37k 119k 0.31

More positions owned by Nuveen

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Micron Technology (MU)
Applied Materials (AMAT)
Lam Research Corp Com New (LRCX)
Advanced Micro Devices (AMD)

View all positions for Nuveen

Top funds holding Ovid Therapeutics

Jupiter Topco
Eventide Asset Management
BlackRock
Henderson Group
RA Capital Management
Affinity Asset Advisors
Vanguard Capital Management
ADAR1 Capital Management
Balyasny Asset Management
Adage Capital Partners GP
Federated Investors
Braidwell
Geode Capital Management
Silverarc Capital Management
Stempoint Capital

View all funds holding Ovid Therapeutics